|
|
Stock Trading History of Ehrlich Christopher BThe following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ehrlich Christopher B since year 2005. The trader's CIK number is 1293973. At the time of this reporting, Ehrlich Christopher B is the Director of Biomimetic Therapeutics, Inc. (stock ticker symbol BMTI).Note that in the past Ehrlich Christopher B also reported insider trading activities as an insider of the following companies:
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ehrlich Christopher B (Director of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website. |